TP53 and RB1 alterations promote reprogramming and antiandrogen resistance in advanced prostate cancer

被引：0
|
作者：
Mu, Ping [1 ]
Cao, Zhen [1 ]
Hoover, Elizabeth [1 ]
Wongvipat, John [1 ]
Huang, Chun-Hao [1 ]
Karthaus, Wouter [1 ]
Abida, Wassim [1 ]
De Stanchina, Elise [1 ]
Sawyers, Charles [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-LB-056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-056
引用
收藏
页数：1
相关论文
共 50 条
  • [1] SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 and RB1 deficient prostate cancer
    Mu, Ping
    Zhang, Zeda
    Benelli, Matteo
    Karthaus, Wouter
    Hoover, Elizebeth
    Chen, Chi-Chao
    Wongvipat, John
    Ku, Sheng-Yu
    Gao, Dong
    Cao, Zhen
    Shah, Neel
    Adams, Elizabeth
    Abida, Wassim
    Watson, Philip
    Prandi, Davide
    Huang, Chun-Hao
    de Stanchina, Elisa
    Lowe, Scott
    Ellis, Leigh
    Beltran, Himisha
    Rubin, Mark
    Goodrich, David
    Demichelis, Francesca
    Sawyers, Charles L.
    [J]. CANCER RESEARCH, 2017, 77
  • [2] RB1 AND TP53 LOSS PROMOTES LINEAGE PLASTICITY IN PROSTATE CANCER
    不详
    [J]. CANCER DISCOVERY, 2017, 7 (03) : 244 - 244
  • [3] Clinical impact of mutations in driver oncogenes and TP53/RB1 in advanced prostate cancer.
    Hammer, Liat
    Rebernick, Ryan
    McFarlane, Matthew
    Westbrook, Thomas
    Hazime, Munna
    Hammoud, Tanya
    Chiu, Pin-en
    Xavier, Owens
    Wu, Yi-Mi
    Robinson, Dan R.
    Spratt, Daniel Eidelberg
    Alva, Ajjai Shivaram
    Jackson, William C.
    Reichert, Zachery R.
    Alumkal, Joshi J.
    Chinnaiyan, Arul
    Cieslik, Marcin
    Dess, Robert Timothy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [4] Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer
    Humid, Anis A.
    Gray, Kathryn P.
    Shaw, Grace
    MacConaill, Laura E.
    Evan, Carolyn
    Bernard, Brandon
    Loda, Massimo
    Corcoran, Niall M.
    Van Allen, Eliezer M.
    Choudhury, Atish D.
    Sweeney, Christopher J.
    [J]. EUROPEAN UROLOGY, 2019, 76 (01) : 89 - 97
  • [5] Locally recurrent prostate cancer with RB1/TP53 alterations successfully treated by salvage focal brachytherapy: a case report
    Komori, Takahiro
    Kosaka, Takeo
    Tanaka, Tomoki
    Watanabe, Keitaro
    Yasumizu, Yota
    Mikami, Shuji
    Oya, Mototsugu
    [J]. AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2023, 11 (04): : 339 - 343
  • [6] Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress
    Nyquist, Michael D.
    Corella, Alexandra
    Coleman, Ilsa
    De Sarkar, Navonil
    Kaipainen, Arja
    Ha, Gavin
    Gulati, Roman
    Ang, Lisa
    Chatterjee, Payel
    Lucas, Jared
    Pritchard, Colin
    Risbridger, Gail
    Isaacs, John
    Montgomery, Bruce
    Morrissey, Colm
    Corey, Eva
    Nelson, Peter S.
    [J]. CELL REPORTS, 2020, 31 (08):
  • [7] A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations
    Kobayashi, Hiroaki
    Kosaka, Takeo
    Nakamura, Kohei
    Shojo, Kazunori
    Hongo, Hiroshi
    Mikami, Shuji
    Nishihara, Hiroshi
    Oya, Mototsugu
    [J]. BMC MEDICAL GENOMICS, 2021, 14 (01)
  • [8] A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations
    Hiroaki Kobayashi
    Takeo Kosaka
    Kohei Nakamura
    Kazunori Shojo
    Hiroshi Hongo
    Shuji Mikami
    Hiroshi Nishihara
    Mototsugu Oya
    [J]. BMC Medical Genomics, 14
  • [9] Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
    Ku, Sheng Yu
    Rosario, Spencer
    Wang, Yanqing
    Mu, Ping
    Seshadri, Mukund
    Goodrich, Zachary W.
    Goodrich, Maxwell M.
    Labbe, David P.
    Gomez, Eduardo Cortes
    Wang, Jianmin
    Long, Henry W.
    Xu, Bo
    Brown, Myles
    Loda, Massimo
    Sawyers, Charles L.
    Ellis, Leigh
    Goodrich, David W.
    [J]. SCIENCE, 2017, 355 (6320) : 78 - 83
  • [10] Evaluating RB1 and p53 as diagnostic markers in treatment-related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53
    Ueki, Hideto
    Jimbo, Naoe
    Terakawa, Tomoaki
    Hara, Takuto
    Tobe, Taisuke
    Hirata, Junichiro
    Wakita, Naoto
    Okamura, Yasuyoshi
    Suzuki, Kotaro
    Bando, Yukari
    Chiba, Koji
    Teishima, Jun
    Nakano, Yuzo
    Miyake, Hideaki
    [J]. PROSTATE, 2024,
12345